Medical imaging technology company Imagion Biosystems (ASX:IBX) has announced changes to its board of directors.
Melanie Leydin has been appointed a non-executive director. Ms Leydin has over 25 years of experience in the accounting profession and over 15 years as a company secretary with extensive experience with public company responsibilities, including ASX and ASIC compliance, control and implementation of corporate governance, statutory financial reporting, re-organisation of companies and shareholder relations.
The company also announced that the departures of Michael Harsh, David Ludvigson and Mark Van Astan from its board.
Managing director and executive chairman Robert Proulx said, “We would like to thank Mr Michael Harsh, Mr David Ludvigson and Mr Mark Van Asten for their years of service and passion to Imagion Biosystems and wish them well for their future endeavours. We are very pleased to welcome Melanie as a Non-Execufive Director of Imagion. Melanie’s experience in the ASX capital markets will be very helpful as we chart our path forward.”